InvestorsHub Logo

cabel

09/19/14 7:57 AM

#69986 RE: Ovidius #69985

Is there a difference bewteen UNBLINDING and Top-Line results,..?

Will we get a PR when the data is unblinded,...?

Great PR,... I like this part:

If we achieve successful data from the recently completed Phase 2 trial, my hope is that people will understand the defensin mimetic’s potential. It’s no longer a world class antibiotic drug, but a world class platform to fight serious public health threats

noretreat

09/19/14 8:08 AM

#69989 RE: Ovidius #69985

In earlier communication we heard 4th quarter and then I believe we heard October. One and a half months would be right around election day. That seems reasonable. We are close to the 28-day follow-up for the last study participants, so the data either is fully collected or will be shortly. Just as an aside, I still don't get why it takes so long to do the so-called analysis. I could do it in a couple of hours, certainly less than a day.

I agree that 2.47 and particularly 2.42 will soon be support.